Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Flat illustration of a tissue sample and research paper in a minimalist style.

Jul 28, 2026

Business Weekly Awards 2026: 44 shortlisted companies revealed for Cambridge Tech and Life Sciences showcase

The Business Weekly Awards 2026 has unveiled its shortlist, highlighting 44 innovative companies in the Cambridge tech and life sciences sectors, showcasing the region's robust ecosystem.The shortlist underscores the dynamic nature of the Cambridge Cluster, particularly its life sciences and technology companies. Many of these contenders have emerged from academic settings, reflecting the area's strong emphasis on research and innovation. Among the notable technology firms are 1956 Individuals,
A minimalist illustration of gears representing collaboration in AI.

Jul 28, 2026

Initech builds AI alliance with AIworks and Hypernology to target enterprise AX

Initech has partnered with AIworks and Hypernology to form an alliance focused on integrating various AI technologies into enterprise applications.On July 28, Initech, AIworks, and Hypernology announced a collaborative agreement to create an "AI alliance" that merges their strengths in industrial artificial intelligence, generative AI, and financial information technology. This partnership aims to identify new business opportunities across sectors such as manufacturing, finance, and public servi
A blood sample in a vial on a lab bench with a syringe.

Jul 28, 2026

Blood Testing Market to Surpass US$ 249.7 Billion by 2035, Fueled

The global blood testing market is projected to exceed $249.7 billion by 2035, driven by advancements in technology and an increasing burden of chronic diseases.The blood testing sector is experiencing significant growth, largely due to healthcare providers' reliance on blood diagnostics for disease detection and monitoring. As a crucial tool for evaluating health, blood tests facilitate early diagnosis and timely medical interventions, enhancing patient outcomes. The market, valued at approxima
An upward trend arrow representing rising healthcare stocks

Jul 28, 2026

Healthcare stocks climb as Gilead, Regeneron and Bristol Myers lead gains across pharma sector

Healthcare stocks experienced a notable uptick, driven by significant gains from key players like Gilead Sciences, Regeneron Pharmaceuticals, and Bristol Myers Squibb.During a recent trading session, the healthcare sector saw a positive shift, with Gilead Sciences rising by 2.88%, closely followed by Regeneron Pharmaceuticals at 2.89%. Bristol Myers Squibb also contributed to the rally with a 2.11% increase. Other major companies, including Zoetis, Johnson & Johnson, Pfizer, Merck, and AbbVie, a
A flat illustration of a proxy drug molecule interacting with a target protein in a laboratory setting.

Jul 28, 2026

Insights from SLAS Europe 2026 - SelectScience interview

At the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), researchers are pioneering the integration of academic research and industrial applications in drug discovery. Their focus is on developing proximity-inducing drugs, which differ from traditional small molecules by modulating protein interactions rather than merely inhibiting protein functions.Proximity-inducing drugs, or proxy drugs, operate by binding to a target protein and recruiting another protein via mechanism
A pill bottle and scattered pills on a pharmacy shelf in dim light.

Jul 28, 2026

AstraZeneca boss urges western drugmakers to move at ‘Chinese speed’

AstraZeneca's CEO, Pascal Soriot, emphasizes the need for Western pharmaceutical companies to adopt a faster pace of innovation, akin to that seen in China's rapidly advancing industry. He warns that without this shift, they risk falling behind more agile competitors, similar to the challenges faced by the Western automotive sector.Soriot's comments reflect a growing concern within the industry about the competitive landscape, particularly as China's pharmaceutical sector continues to innovate a
A minimalist representation of a single cell and gene strands in a dark palette.

Jul 28, 2026

Novogene Europe Adds Single-Cell Sequencing at Cambridge Omics Centre

Novogene Europe has enhanced its single-cell RNA sequencing capabilities at the Cambridge Omics Centre, providing advanced sequencing services to researchers in the UK.This development leverages Novogene's established expertise in single-cell technologies, integrating specialized project support, sequencing infrastructure, and bioinformatics analysis. The aim is to facilitate deeper biological insights from complex samples, responding to the increasing demand for accessible single-cell transcrip
Handheld diagnostic device for COPD testing on a wooden table in a clinical setting.

Jul 28, 2026

Tidalsense raises $19M for AI-powered COPD diagnostic platform

Tidalsense Ltd. has successfully secured $19 million in funding to advance its AI-driven diagnostic platform aimed at identifying chronic obstructive pulmonary disease (COPD).The company’s N-Tidal Diagnose platform offers a rapid diagnostic test that can detect COPD within five minutes. This innovative approach involves a simple procedure where users breathe normally into a handheld device for 75 seconds, capturing a carbon dioxide breath waveform. The data is then analyzed using artificial inte
A vial of medication on a laboratory shelf in a dimly lit setting.

Jul 27, 2026

AstraZeneca boss urges western drugmakers to move at ‘Chinese speed’

AstraZeneca's CEO, Pascal Soriot, emphasizes the need for Western pharmaceutical companies to adopt a faster pace of innovation, akin to that of China's rapidly advancing drug industry. He warns that without this shift, they risk losing competitiveness, similar to the challenges faced by the Western automotive sector.Soriot highlighted AstraZeneca's commitment to achieving ambitious growth targets, aiming for $80 billion in annual sales by 2030. The company reported a 6% revenue increase in the
A minimalist chatbot icon on a lime background

Jul 27, 2026

ChapsVision aims to become Europe’s AI champion amid Palantir skepticism

ChapsVision is emerging as a significant player in Europe’s AI landscape, having recently replaced Palantir at France's domestic intelligence agency, DGSI, with its ArgonOS system.Founded in 2019, ChapsVision has rapidly expanded, now employing around 1,000 people and generating approximately €200 million in revenue for the fiscal year 2024/2025. This strategic shift is part of France's broader initiative to enhance digital sovereignty and reduce reliance on foreign technology, with the governme
Handheld diagnostic device for COPD testing on a wooden table in a clinical setting.

Jul 27, 2026

Tidalsense raises $19M for AI-powered COPD diagnostic platform

Tidalsense Ltd. has successfully secured $19 million in funding to advance its AI-driven diagnostic platform, N-Tidal Diagnose, aimed at detecting chronic obstructive pulmonary disease (COPD) swiftly and efficiently.The N-Tidal Diagnose platform utilizes a handheld device that captures a carbon dioxide breath waveform from users who breathe normally for 75 seconds. This data is then analyzed using artificial intelligence to provide a diagnosis of COPD in as little as five minutes. This innovatio
A radiologist examining a chest X-ray in a dimly lit room.

Jul 27, 2026

Why Aidoc is taking a generative AI device to the FDA

Aidoc is advancing its generative AI tool, First Read, towards FDA approval, highlighting its potential to transform radiology diagnostics.In June, the FDA granted Aidoc a breakthrough designation for First Read, a generative AI tool designed to analyze chest X-rays and produce reports for radiologists. This designation allows for expedited review, reflecting the FDA's ongoing exploration of generative AI applications in medical devices. Aidoc's system aims to identify over 100 diseases, providi